{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2008-N-0567\" sorted by posted_date descending", "rows": [["FDA-2008-N-0567-0167", "FDA", "FDA-2008-N-0567", "Notice of Decision Not To Designate Coccidioidomycosis as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Notice", "General Notice", "2020-07-15T04:00:00Z", 2020, 7, "2020-07-15T04:00:00Z", null, "2020-07-15T13:09:33Z", "2020-15255", 0, 0, "0900006484763953"], ["FDA-2008-N-0567-0169", "FDA", "FDA-2008-N-0567", "Notice of Decision Not To Designate Clonorchiasis as an Addition to the\nCurrent List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Notice", "Designations", "2020-07-15T04:00:00Z", 2020, 7, "2020-07-15T04:00:00Z", null, "2020-07-15T13:52:03Z", "2020-15253", 0, 0, "09000064847639d9"], ["FDA-2008-N-0567-0168", "FDA", "FDA-2008-N-0567", "Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Notice", "Notice of Final Rule", "2020-07-15T04:00:00Z", 2020, 7, "2020-07-15T04:00:00Z", null, "2020-07-15T13:42:40Z", "2020-15252", 0, 0, "09000064847639a5"], ["FDA-2008-N-0567-0170", "FDA", "FDA-2008-N-0567", "Designating Additions to the Current List of Tropical Diseases in the Federal\nFood, Drug, and Cosmetic Act", "Notice", "Notice of Final Rule", "2020-07-15T04:00:00Z", 2020, 7, "2020-07-15T04:00:00Z", null, "2020-07-15T14:07:24Z", "2020-15254", 0, 0, "0900006484763a81"], ["FDA-2008-N-0567-0055", "FDA", "FDA-2008-N-0567", "Designating Additions to the Current List of Tropical Diseases in the Federal\nFood, Drug, and Cosmetic Act", "Notice", "Notice of Final Rule", "2018-08-24T04:00:00Z", 2018, 8, "2018-08-24T04:00:00Z", null, "2024-11-07T01:04:55Z", "2018-18314", 1, 0, "090000648364f86f"], ["FDA-2008-N-0567-0081", "FDA", "FDA-2008-N-0567", "002 Reference 1 - Chikungunya - epidemiology", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:56Z", null, 0, 0, "090000648365031a"], ["FDA-2008-N-0567-0110", "FDA", "FDA-2008-N-0567", "015 Reference 14 - Burden of Chikungunya in India - Estimates of DALY Lost in 2006 Epidemic", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:17Z", null, 0, 0, "09000064836505b0"], ["FDA-2008-N-0567-0111", "FDA", "FDA-2008-N-0567", "014 Reference 13 - Morbidity and Impaired Quality of Life 30 Months After Chikungunya Infection", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:17Z", null, 0, 0, "0900006483650340"], ["FDA-2008-N-0567-0140", "FDA", "FDA-2008-N-0567", "053 Reference 52 - Global Report UNAIDS Report on the Global AIDS Epidemic 2013", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:39Z", null, 0, 0, "09000064836503cd"], ["FDA-2008-N-0567-0091", "FDA", "FDA-2008-N-0567", "028 Reference 27 - Predictors of Pneumocystis carinii pneumonia in HIV-infected persons", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:02Z", null, 0, 0, "0900006483650546"], ["FDA-2008-N-0567-0126", "FDA", "FDA-2008-N-0567", "041 Reference 40 - Cost of Rabies Prevention", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:29Z", null, 0, 0, "0900006483650397"], ["FDA-2008-N-0567-0125", "FDA", "FDA-2008-N-0567", "042 Reference 41 - Cryptococcosis- Epidemiology, Fungal Resistance, and New Alternatives for Treatment", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:29Z", null, 0, 0, "09000064836503be"], ["FDA-2008-N-0567-0119", "FDA", "FDA-2008-N-0567", "048 Reference 47 - The Changing Epidemiology of Cryptococcosis - An Update from Population-Based Active Surveillance in 2 Large Metropolitan Areas, 1992-2000", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:25Z", null, 0, 0, "09000064836503c4"], ["FDA-2008-N-0567-0144", "FDA", "FDA-2008-N-0567", "049 Reference 48 - Epidemiology of Cryptococcal Meningitis in the US", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:42Z", null, 0, 0, "09000064836503c5"], ["FDA-2008-N-0567-0057", "FDA", "FDA-2008-N-0567", "020 Reference 19 - Burden of serious fungal infections in Tanzania", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:38Z", null, 0, 0, "0900006483650535"], ["FDA-2008-N-0567-0137", "FDA", "FDA-2008-N-0567", "030 Reference 29 - Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:36Z", null, 0, 0, "09000064836505ff"], ["FDA-2008-N-0567-0068", "FDA", "FDA-2008-N-0567", "009 Reference 8 - Polymerase chain reactions for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:45Z", null, 0, 0, "09000064836500ff"], ["FDA-2008-N-0567-0107", "FDA", "FDA-2008-N-0567", "018 Reference 17 - Neglected Tropical Diseases", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:15Z", null, 0, 0, "09000064836505b3"], ["FDA-2008-N-0567-0074", "FDA", "FDA-2008-N-0567", "003 Reference 2 - HIV Surveillance Report 2015", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:49Z", null, 0, 0, "09000064836500f9"], ["FDA-2008-N-0567-0071", "FDA", "FDA-2008-N-0567", "006 Reference 5 - Key Statistics for Acute Lymphocytic Leukemia", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:47Z", null, 0, 0, "09000064836500fc"], ["FDA-2008-N-0567-0066", "FDA", "FDA-2008-N-0567", "011 Reference 10 - AIDS-defining opportunistic illnesses in US patients", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:43Z", null, 0, 0, "09000064836502bd"], ["FDA-2008-N-0567-0064", "FDA", "FDA-2008-N-0567", "013 Reference 12 - Pneumocystis species", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:42Z", null, 0, 0, "09000064836502bf"], ["FDA-2008-N-0567-0063", "FDA", "FDA-2008-N-0567", "014 Reference 13 - Pneumocystic pneumonia CDC", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:42Z", null, 0, 0, "09000064836502c0"], ["FDA-2008-N-0567-0108", "FDA", "FDA-2008-N-0567", "017 Reference 16 - Severe Manifestations of Chikungunya Virus in Critically Ill Patients During the 2013-2014 Caribbean Outbreak", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:15Z", null, 0, 0, "09000064836505b2"], ["FDA-2008-N-0567-0106", "FDA", "FDA-2008-N-0567", "019 Reference 18 - Lymphocytic Choriomenengitis, Lassa Fever, and South American Hemorrhagic Fevers", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:14Z", null, 0, 0, "09000064836505b4"], ["FDA-2008-N-0567-0098", "FDA", "FDA-2008-N-0567", "027 Reference 26 - Essential Medicines and Health Products - WHO Publishes List of Top Emerging Diseases Likely To Cause Major Epidemics", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:09Z", null, 0, 0, "09000064836505fc"], ["FDA-2008-N-0567-0116", "FDA", "FDA-2008-N-0567", "009 Reference 8 - Chikungunya 2015 Final Data for the United States", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:20Z", null, 0, 0, "0900006483650339"], ["FDA-2008-N-0567-0094", "FDA", "FDA-2008-N-0567", "025 Reference 24 - Burden of serious fungal infections in Nepal", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:04Z", null, 0, 0, "090000648365053a"], ["FDA-2008-N-0567-0090", "FDA", "FDA-2008-N-0567", "029 Reference 28 - Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:01Z", null, 0, 0, "0900006483650547"], ["FDA-2008-N-0567-0077", "FDA", "FDA-2008-N-0567", "006 Reference 5 - Towards Antivirals Against Chikungunya Virus", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:53Z", null, 0, 0, "090000648365031e"], ["FDA-2008-N-0567-0115", "FDA", "FDA-2008-N-0567", "010 Reference 9 - Chikungunya", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:19Z", null, 0, 0, "090000648365033a"], ["FDA-2008-N-0567-0123", "FDA", "FDA-2008-N-0567", "044 Reference 43 - New Approaches to the Diagnosis and Treatment of Cryptococcal Meningitis", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:27Z", null, 0, 0, "09000064836503c0"], ["FDA-2008-N-0567-0122", "FDA", "FDA-2008-N-0567", "045 Reference 44 - Clinical Practice Guidelines for the Management of Cryptococcal Disease", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:27Z", null, 0, 0, "09000064836503c1"], ["FDA-2008-N-0567-0120", "FDA", "FDA-2008-N-0567", "047 Reference 46 - Estimation of the Current Global Burden of Cryptococcal Meningitis Among Persons Living with HIV AIDS", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:26Z", null, 0, 0, "09000064836503c3"], ["FDA-2008-N-0567-0097", "FDA", "FDA-2008-N-0567", "022 Reference 21 - Cryptococcal disease and the burden of other fungal diseases in Uganda", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:06Z", null, 0, 0, "0900006483650537"], ["FDA-2008-N-0567-0062", "FDA", "FDA-2008-N-0567", "015 Reference 14 - USPHS IDSA Guidelines for the Prevention of Opportunistic infections in Persons Infected with HIV", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:41Z", null, 0, 0, "09000064836502c1"], ["FDA-2008-N-0567-0078", "FDA", "FDA-2008-N-0567", "005 Reference 4 - Persistent Arthralgia Associated With Chikungunya Virus", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:53Z", null, 0, 0, "090000648365031d"], ["FDA-2008-N-0567-0136", "FDA", "FDA-2008-N-0567", "031 Reference 30 - WHO Guide for Rabies Pre and Post Exposure Prophylaxis in Humans (updated 2014)", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:35Z", null, 0, 0, "0900006483650600"], ["FDA-2008-N-0567-0134", "FDA", "FDA-2008-N-0567", "033 Reference 32 - Distribution of Risk Levels for Humans Contacting Rabies,", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:34Z", null, 0, 0, "0900006483650602"], ["FDA-2008-N-0567-0124", "FDA", "FDA-2008-N-0567", "043 Reference 42 - C. neoformans Infection Statistics", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:28Z", null, 0, 0, "09000064836503bf"], ["FDA-2008-N-0567-0087", "FDA", "FDA-2008-N-0567", "032 Reference 31 - Risk Factors for Mortality from Acute Lower Respiratory Infections in Children under Five Years of Age in Low and Middle-Income Countries", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:59Z", null, 0, 0, "090000648365054a"], ["FDA-2008-N-0567-0072", "FDA", "FDA-2008-N-0567", "005 Reference 4 - Transplant Activity Report Total Transplants By Year", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:48Z", null, 0, 0, "09000064836500fb"], ["FDA-2008-N-0567-0070", "FDA", "FDA-2008-N-0567", "007 Reference 6 - Pneumocystis pneumonia associated with human immunodeficiency virus", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:46Z", null, 0, 0, "09000064836500fd"], ["FDA-2008-N-0567-0065", "FDA", "FDA-2008-N-0567", "012 Reference 11 - Increasing pneumocystis pneumonia England, UK, 2000-2010", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:43Z", null, 0, 0, "09000064836502be"], ["FDA-2008-N-0567-0118", "FDA", "FDA-2008-N-0567", "007 Reference 6 - The Global Virus Network Challenging Chikungunya", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:21Z", null, 0, 0, "0900006483650323"], ["FDA-2008-N-0567-0117", "FDA", "FDA-2008-N-0567", "008 Reference 7 - Why Arboviruses Can Be Neglected Tropical Diseases", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:20Z", null, 0, 0, "0900006483650337"], ["FDA-2008-N-0567-0058", "FDA", "FDA-2008-N-0567", "019 Reference 18 - Burden of serious fungal infections in Belgium", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:39Z", null, 0, 0, "0900006483650534"], ["FDA-2008-N-0567-0096", "FDA", "FDA-2008-N-0567", "023 Reference 22 - Estimating the burden of fungal disease in Vietnam", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:05Z", null, 0, 0, "0900006483650538"], ["FDA-2008-N-0567-0093", "FDA", "FDA-2008-N-0567", "026 Reference 25 - Burden of serious fungal infections in Ukraine", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:03Z", null, 0, 0, "090000648365053b"], ["FDA-2008-N-0567-0086", "FDA", "FDA-2008-N-0567", "033 Reference 32 - Current epidemiology of Pneumocystis pneumonia", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:59Z", null, 0, 0, "090000648365054b"], ["FDA-2008-N-0567-0073", "FDA", "FDA-2008-N-0567", "004 Reference 3 - 2015 UNOS Annual Report", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:48Z", null, 0, 0, "09000064836500fa"], ["FDA-2008-N-0567-0061", "FDA", "FDA-2008-N-0567", "016 Reference 15 - The spectrum of clinical and pathological manifestations of AIDS in a consecutive serious of autopsied patients in Mexico", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:40Z", null, 0, 0, "09000064836502c2"], ["FDA-2008-N-0567-0104", "FDA", "FDA-2008-N-0567", "021 Reference 20 - Acute Sensorineural Deafness in Lassa Fever", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:13Z", null, 0, 0, "09000064836505b6"], ["FDA-2008-N-0567-0103", "FDA", "FDA-2008-N-0567", "022 Reference 21 - Lassa Fever Confirmed in Death of U.S. Traveler Returning from Liberia", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:12Z", null, 0, 0, "09000064836505b8"], ["FDA-2008-N-0567-0135", "FDA", "FDA-2008-N-0567", "032  Reference 31 - WHO Expert Consultation on Rabies, 2nd Report, WHO Technical Report Series 982 Geneva", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:35Z", null, 0, 0, "0900006483650601"], ["FDA-2008-N-0567-0131", "FDA", "FDA-2008-N-0567", "036 Reference 35 - Annual Estimates of the Resident Population April 1, 2010 to July 1, 2015", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:32Z", null, 0, 0, "0900006483650390"], ["FDA-2008-N-0567-0129", "FDA", "FDA-2008-N-0567", "038 Reference 37 - Facts about rabies", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:31Z", null, 0, 0, "0900006483650394"], ["FDA-2008-N-0567-0143", "FDA", "FDA-2008-N-0567", "050 Reference 49 - Emergence of Cryptococcus gattii--Pacific Northwest, 2004-2010", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:41Z", null, 0, 0, "09000064836503c6"], ["FDA-2008-N-0567-0089", "FDA", "FDA-2008-N-0567", "030 Reference 29 - Pneumocystis carinii pneumonia in patients in the developing world who have AIDS", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:01Z", null, 0, 0, "0900006483650548"], ["FDA-2008-N-0567-0054", "FDA", "FDA-2008-N-0567", "Notice of Decision Not To Designate Pneumocystis Pneumonia as a Tropical Disease", "Notice", "General Notice", "2018-08-24T04:00:00Z", 2018, 8, "2018-08-24T04:00:00Z", null, "2018-08-24T12:55:10Z", "2018-18313", 0, 0, "090000648364f81d"], ["FDA-2008-N-0567-0132", "FDA", "FDA-2008-N-0567", "035 Reference 34 - Epidemiology of Rabies Post-Exposure Prophylaxis--United States of America, 2006-2008", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:33Z", null, 0, 0, "090000648365038f"], ["FDA-2008-N-0567-0059", "FDA", "FDA-2008-N-0567", "018 Reference 17 - Respiratory complications in Brazilian patients infected with HIV", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:39Z", null, 0, 0, "0900006483650533"], ["FDA-2008-N-0567-0076", "FDA", "FDA-2008-N-0567", "001 Reference List", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:50Z", null, 0, 0, "09000064836500f7"], ["FDA-2008-N-0567-0079", "FDA", "FDA-2008-N-0567", "004 Reference 3 - French Guidelines for the Management of Chikungunya", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:54Z", null, 0, 0, "090000648365031c"], ["FDA-2008-N-0567-0105", "FDA", "FDA-2008-N-0567", "020 Reference 19 - Imported Lassa Fever --- New Jersey, 2004", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:13Z", null, 0, 0, "09000064836505b5"], ["FDA-2008-N-0567-0060", "FDA", "FDA-2008-N-0567", "017 Reference 16 - Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok Thailand", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:40Z", null, 0, 0, "09000064836502c5"], ["FDA-2008-N-0567-0085", "FDA", "FDA-2008-N-0567", "034 Reference 33 - Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:58Z", null, 0, 0, "090000648365054c"], ["FDA-2008-N-0567-0083", "FDA", "FDA-2008-N-0567", "036 Reference 35 - Neglected Tropical Diseases", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:57Z", null, 0, 0, "090000648365054e"], ["FDA-2008-N-0567-0112", "FDA", "FDA-2008-N-0567", "013 Reference 12 - Measuring the Burden of Arboviral Diseases The Spectrum of Morbidity and Mortality from Four Prevalent Infections", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:18Z", null, 0, 0, "090000648365033f"], ["FDA-2008-N-0567-0133", "FDA", "FDA-2008-N-0567", "034 Reference 33 - Rabies Surveillance in the United States During 2014", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:33Z", null, 0, 0, "090000648365038e"], ["FDA-2008-N-0567-0130", "FDA", "FDA-2008-N-0567", "037 Reference 36 - Rabies Fact Sheet", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:32Z", null, 0, 0, "0900006483650393"], ["FDA-2008-N-0567-0095", "FDA", "FDA-2008-N-0567", "024 Reference 23 - Burden of fungal infections in Senegal", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:04Z", null, 0, 0, "0900006483650539"], ["FDA-2008-N-0567-0080", "FDA", "FDA-2008-N-0567", "003 Reference 2 - Seroprevalence of Chikungunya Virus Infection on Grande Comore Island, Union of the Comoros, 2005 2", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:55Z", null, 0, 0, "090000648365031b"], ["FDA-2008-N-0567-0102", "FDA", "FDA-2008-N-0567", "023 Reference 22 - Public Health Assessment of Potential Biological Terrorism Agents", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:12Z", null, 0, 0, "09000064836505b9"], ["FDA-2008-N-0567-0101", "FDA", "FDA-2008-N-0567", "024 Reference 23 - Hemorrhagic Fever Viruses as Biological Weapons", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:11Z", null, 0, 0, "09000064836505f9"], ["FDA-2008-N-0567-0099", "FDA", "FDA-2008-N-0567", "026 Reference 25 - 2017-2018 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:10Z", null, 0, 0, "09000064836505fb"], ["FDA-2008-N-0567-0128", "FDA", "FDA-2008-N-0567", "039 Reference 38 - Expert Consultation on Rabies Post-Exposure Prophylaxis", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:30Z", null, 0, 0, "0900006483650395"], ["FDA-2008-N-0567-0127", "FDA", "FDA-2008-N-0567", "040 Reference 39 - Immunizations and Chemoprophlaxis for the Prevention of Infectious Diseases", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:30Z", null, 0, 0, "0900006483650396"], ["FDA-2008-N-0567-0142", "FDA", "FDA-2008-N-0567", "051 Reference 50 - Current Trends in the Prevalence of Cryptococcus Gattii in the United States and Canada", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:40Z", null, 0, 0, "09000064836503c7"], ["FDA-2008-N-0567-0056", "FDA", "FDA-2008-N-0567", "021 Reference 20 - Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:37Z", null, 0, 0, "0900006483650536"], ["FDA-2008-N-0567-0113", "FDA", "FDA-2008-N-0567", "012 Reference 11 - Chikungunya Infection in DOD Healthcare Beneficiaries Following the 2013 Introduction of the Virus", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:18Z", null, 0, 0, "090000648365033e"], ["FDA-2008-N-0567-0141", "FDA", "FDA-2008-N-0567", "052 Reference 51 - Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:40Z", null, 0, 0, "09000064836503cc"], ["FDA-2008-N-0567-0067", "FDA", "FDA-2008-N-0567", "010 Reference 9 - An estimateof the burden of serious fungal diseases in Greece", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:44Z", null, 0, 0, "0900006483650500"], ["FDA-2008-N-0567-0088", "FDA", "FDA-2008-N-0567", "031 Reference 30 - Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:00Z", null, 0, 0, "0900006483650549"], ["FDA-2008-N-0567-0084", "FDA", "FDA-2008-N-0567", "035 Reference 34 - Global Report UNAIDS report on the global AIDS epidemic 2013", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:57Z", null, 0, 0, "090000648365054d"], ["FDA-2008-N-0567-0109", "FDA", "FDA-2008-N-0567", "016 Reference 15 - Measuring the Burden of Arboviral Diseases", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:16Z", null, 0, 0, "09000064836505b1"], ["FDA-2008-N-0567-0138", "FDA", "FDA-2008-N-0567", "029 Reference 28 - Rhabdoviruses", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:36Z", null, 0, 0, "09000064836505fe"], ["FDA-2008-N-0567-0082", "FDA", "FDA-2008-N-0567", "001 Reference List", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:56Z", null, 0, 0, "090000648365054f"], ["FDA-2008-N-0567-0100", "FDA", "FDA-2008-N-0567", "025 Reference 24 - Zoonoses Likely to be Used in Bioterrorism", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:10Z", null, 0, 0, "09000064836505fa"], ["FDA-2008-N-0567-0114", "FDA", "FDA-2008-N-0567", "011 Reference 10 - Chikungunya Virus Geographic Distribution", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:19Z", null, 0, 0, "090000648365033c"], ["FDA-2008-N-0567-0121", "FDA", "FDA-2008-N-0567", "046 Reference 45 - A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:26Z", null, 0, 0, "09000064836503c2"], ["FDA-2008-N-0567-0092", "FDA", "FDA-2008-N-0567", "027 Reference 26 - Pneumocystis pneumonia in South African children with and without HIV infection in the era of HAART", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:02Z", null, 0, 0, "090000648365053c"], ["FDA-2008-N-0567-0075", "FDA", "FDA-2008-N-0567", "002 Reference 1 - Pneumocystis pneumonia", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:49Z", null, 0, 0, "09000064836500f8"], ["FDA-2008-N-0567-0069", "FDA", "FDA-2008-N-0567", "008 Reference 7 - Current epidemiology of pneumocystis pneumonia", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:01:46Z", null, 0, 0, "09000064836500fe"], ["FDA-2008-N-0567-0139", "FDA", "FDA-2008-N-0567", "028 Reference 27 - 2017 Annual Review of Diseases Prioritized Under the Research and Development Blueprint", "Supporting & Related Material", "Background Material", "2018-08-24T04:00:00Z", 2018, 8, null, null, "2018-08-24T18:02:37Z", null, 0, 0, "09000064836505fd"], ["FDA-2008-N-0567-0025", "FDA", "FDA-2008-N-0567", "Reference 13 - Marginalize re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Supporting & Related Material", "Background Material", "2015-08-20T04:00:00Z", 2015, 8, null, null, "2015-08-20T17:00:59Z", null, 0, 0, "0900006481c28cd7"], ["FDA-2008-N-0567-0028", "FDA", "FDA-2008-N-0567", "Reference 16 - Parasites--American Trypanosomiasis (also known as Chagas Disease) Detailed FAQs re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Supporting & Related Material", "Background Material", "2015-08-20T04:00:00Z", 2015, 8, null, null, "2015-08-20T17:01:18Z", null, 0, 0, "0900006481c28cda"], ["FDA-2008-N-0567-0035", "FDA", "FDA-2008-N-0567", "Reference 23 - Neurocysticercosis A Disease of Neglect re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Supporting & Related Material", "Background Material", "2015-08-20T04:00:00Z", 2015, 8, null, null, "2015-08-20T17:02:05Z", null, 0, 0, "0900006481c28ce1"], ["FDA-2008-N-0567-0036", "FDA", "FDA-2008-N-0567", "Reference 24 - The Burden of Cysticercosis re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Supporting & Related Material", "Background Material", "2015-08-20T04:00:00Z", 2015, 8, null, null, "2015-08-20T17:02:13Z", null, 0, 0, "0900006481c28ce2"], ["FDA-2008-N-0567-0037", "FDA", "FDA-2008-N-0567", "Reference 25 - Neurocysticercosis in the United States Review of an Important Emerging Infection re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act", "Supporting & Related Material", "Background Material", "2015-08-20T04:00:00Z", 2015, 8, null, null, "2015-08-20T17:02:19Z", null, 0, 0, "0900006481c28ce3"]], "truncated": false, "filtered_table_rows_count": 125, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2008-N-0567"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567", "results": [{"value": "FDA", "label": "FDA", "count": 125, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2008-N-0567", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 116, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&document_type=Other", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567", "results": [{"value": 2018, "label": 2018, "count": 91, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&posted_year=2018", "selected": false}, {"value": 2015, "label": 2015, "count": 28, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&posted_year=2015", "selected": false}, {"value": 2020, "label": 2020, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&posted_year=2020", "selected": false}, {"value": 2008, "label": 2008, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&posted_year=2009", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_facet_date=last_modified"}], "next": "2015-08-20T04~3A00~3A00Z,FDA-2008-N-0567-0037", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0567&_next=2015-08-20T04~3A00~3A00Z%2CFDA-2008-N-0567-0037&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 70.71174192242324, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}